98%
921
2 minutes
20
Objective: Mental health and burnout are major concerns among medical students, yet poor utilization of care persists. Barriers to care for medical students were identified in a previous study. Following this, a no-cost, confidential Medical Student Mental Health Program (MSMHP) was established to address common barriers to care. This study provides an analysis 1 year following the implementation of the MSMHP as well as a comparison to student attitudes and service utilization with the pre-implementation survey.
Methods: In early 2023, a survey eliciting information regarding student burnout, barriers to care, and resource utilization and satisfaction was sent to 780 current medical students. Participation was anonymous and voluntary, with optional responses to each question.
Results: Ultimately, 387 (50%) medical students responded. Burnout remained at similar levels between years (2020, 2.60; 2023, 2.59), as well as students reporting either a new or previously perceived mental health concern (2020, 67%; 2023, 65%). Satisfaction with the availability of mental health resources for medical students significantly increased since MSMHP implementation; 74% were "very" or "somewhat" satisfied in 2023, compared with 39% in 2020. While we found that the program addressed the barrier of access, barriers of stigma, time, fear of future disclosure, and cost remained.
Conclusion: This study demonstrated that following the implementation of a MSMHP, a greater proportion of medical students obtained mental health care. Despite this, student burnout and concern over mental health and emotional well-being remained high. This may be explained by persistent systemic issues and barriers to care within the medical school experience.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s40596-025-02193-9 | DOI Listing |
J Med Internet Res
September 2025
Department of Psychiatry, Helsinki University Hospital and Helsinki University, Helsinki, Finland.
Background: Internet-based cognitive behavioral therapies (iCBTs) are typically categorized into 2 types: therapist-assisted and self-guided. Both formats have accumulated substantial evidence supporting their cost-effectiveness and efficacy in treating a range of mental health conditions. However, therapist-assisted iCBTs tend to show lower dropout rates than self-guided versions.
View Article and Find Full Text PDFJMIR Ment Health
September 2025
National Institute of Health and Care Research MindTech HealthTech Research Centre, School of Medicine, University of Nottingham, Nottingham, United Kingdom.
Background: Cross-sector collaboration is increasingly recognized as essential for addressing complex health challenges, including those in mental health. Industry-academic partnerships play a vital role in advancing research and developing health solutions, yet differing priorities and perspectives can make collaboration complex.
Objective: This study aimed to identify key principles to support effective industry-academic partnerships, from the perspective of industry partners, and develop this into actionable guidance, which can be applied across sectors.
JMIR Res Protoc
September 2025
National Institute of Public Health, University of Southern Denmark, Copenhagen K, Denmark.
Background: The high and increasing rate of poor mental health among young people is a matter of global concern. Experiencing poor mental health during this formative stage of life can adversely impact interpersonal relationships, academic and professional performance, and future health and well-being if not addressed early. However, only a few of those in need seek help.
View Article and Find Full Text PDFNeuro Endocrinol Lett
September 2025
Sichuan Provincial Center for Mental Health, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China.
Background: Major depressive disorder (MDD) is associated with neuro-immune - metabolic - oxidative (NIMETOX) pathways.
Aims: To examine the connections among NIMETOX pathways in outpatient MDD (OMDD) with and without metabolic syndrome (MetS); and to determine the prevalence of NIMETOX aberrations in a cohort of OMDD patients.
Methods: We included 67 healthy controls and 66 OMDD patients and we assessed various NIMETOX pathways.